Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Moran

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Zoonoses and Public Health|February 26, 2025
High Mycobacterium bovis Exposure but Low IGRA Positivity in UK Farm WorkersAmy Thomas, Alice Halliday, Genevieve Clapp, et al.
Thorax|December 4, 2020
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohortDavid T Arnold, Fergus W Hamilton, Alice Milne, et al.
The Journal of Allergy and Clinical Immunology|November 15, 2021
Treatment of chronic or relapsing COVID-19 in immunodeficiencyLi-An K Brown, Ed Moran, Anna Goodman, et al.
Lancet (London, England)|November 14, 2021
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trialRajeka Lazarus, Sarah Baos, Heike Cappel-Porter, et al.
The Lancet. Infectious Diseases|June 22, 2023
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trialIvan T Lee, Catherine A Cosgrove, Patrick Moore, et al.
The Journal of Infection|June 5, 2026
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trialRosie Harris, Russell Thirard, Claire McBrien, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Zoonoses and Public Health|February 26, 2025
High Mycobacterium bovis Exposure but Low IGRA Positivity in UK Farm WorkersAmy Thomas, Alice Halliday, Genevieve Clapp, et al.
Thorax|December 4, 2020
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohortDavid T Arnold, Fergus W Hamilton, Alice Milne, et al.
The Journal of Allergy and Clinical Immunology|November 15, 2021
Treatment of chronic or relapsing COVID-19 in immunodeficiencyLi-An K Brown, Ed Moran, Anna Goodman, et al.
Lancet (London, England)|November 14, 2021
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trialRajeka Lazarus, Sarah Baos, Heike Cappel-Porter, et al.
The Lancet. Infectious Diseases|June 22, 2023
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trialIvan T Lee, Catherine A Cosgrove, Patrick Moore, et al.
The Journal of Infection|June 5, 2026
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trialRosie Harris, Russell Thirard, Claire McBrien, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 3